Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Nevi, Melanocytic

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Nevi, Melanocytic in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aziz, SA1
Davies, M1
Pick, E1
Zito, C1
Jilaveanu, L1
Camp, RL1
Rimm, DL1
Kluger, Y1
Kluger, HM1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Nevi, Melanocytic

ArticleYear
Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-01, Volume: 15, Issue:9

    Topics: Brain Neoplasms; Cell Proliferation; Chromones; Enzyme Inhibitors; Humans; Immunoblotting; Immunoenz

2009